Indonesia's Bio Farma says not yet able to determine Sinovac vaccine efficacy


Modified 8 Dec 2020, 3:19 pm

Indonesia's state-owned pharmaceutical company Bio Farma said today that interim data on trials it was conducting on vaccines produced by the Chinese company Sinovac showed up to 97 percent efficacy.

"Our clinical trial team found, within one month, that the interim data shows up to 97 percent for its efficacy," said Iwan Setiawan, a spokesperson for Bio Farma, at a news conference...

All Access Plan
starting from


per month
Subscribe Now
You can cancel anytime.
Get unlimited access to our articles on web and apps
Add comments to our articles
Bookmark articles to read later
We accept
Student or Senior Citizen? Get a special rateGroup / Institutional / Corporate Plans
Already Subscribed?
Sign In